Urology and Nephrology Research center, Shahid Beheshti University (MC), Tehran, Iran.
J Hum Genet. 2010 Sep;55(9):565-70. doi: 10.1038/jhg.2010.59. Epub 2010 May 27.
The effects of the GST genes (GSTM1, GSTT1 and GSTP1) on male factor infertility have not been well elucidated. A case-control study was performed to investigate the association between functionally important polymorphisms in GST genes and idiopathic male infertility. The study group consisted of 166 men suffering from idiopathic oligoasthenoteratozoospermia (OAT) and an equal number of age-matched healthy fertile male controls. Genomic DNA extracted from the peripheral blood, was analyzed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) methods. Multivariate regression analysis showed an increase in risk to infertility in the patients with null genotype of GSTM1 (OR: 2.18; 95% CI: 1.64-3.32; P=0.001) or GSTT1 (OR: 1.88; 95% CI:1.12-2.52; P=0.04). Our data further showed that combination of deletion genotypes of GST (GSTM1 and GSTT1) pose an even higher risk of infertility. In addition, GSTP1 wild-type genotype in combination with GSTM1 null or GSTT1 null genotype increased probability for infertility (OR: 2.47, 95% CI: 1.46-4.17: and OR: 2.69, 95% CI: 1.39-5.32, respectively). Similarly a much higher risk for infertility was noted in the patients carrying a genotype combination of GSTM1 null, GSTT1 null and GSTP1 (Ile/Ile) (OR: 4.45; 95% CI: 1.59-12.24; P=0.002). The variant genotypes of GSTP1 (Ile/Val and Val/Val) resulted in a significant decreased risk to infertility in the cases (OR: 0.44; 95% CI: 0.29-0.78, P=0.004). These results support the hypothesis of increased risk of GSTM1 or GSTT1null genotypes for developing infertility, but the nondeletion GSTM1 and GSTT1genotypes emerged as protective factors.
谷胱甘肽 S-转移酶基因(GSTM1、GSTT1 和 GSTP1)对男性因素不孕的影响尚未得到充分阐明。本病例对照研究旨在探讨 GST 基因中功能重要的多态性与特发性男性不育之间的关系。研究组包括 166 名患有特发性少精弱精症(OAT)的男性患者和相同数量年龄匹配的健康生育男性对照组。从外周血中提取基因组 DNA,采用聚合酶链反应(PCR)和限制性片段长度多态性(RFLP)方法进行分析。多变量回归分析显示,GSTM1 (OR:2.18;95%CI:1.64-3.32;P=0.001)或 GSTT1 (OR:1.88;95%CI:1.12-2.52;P=0.04)纯合缺失基因型的患者不孕风险增加。我们的数据还表明,GST(GSTM1 和 GSTT1)缺失基因型的组合会增加不孕的风险。此外,GSTM1 缺失或 GSTT1 缺失基因型与 GSTP1 野生型基因型相结合会增加不孕的可能性(OR:2.47,95%CI:1.46-4.17;和 OR:2.69,95%CI:1.39-5.32)。同样,在携带 GSTM1 缺失、GSTT1 缺失和 GSTP1(Ile/Ile)基因型组合的患者中,也观察到更高的不孕风险(OR:4.45;95%CI:1.59-12.24;P=0.002)。GSTP1 的变体基因型(Ile/Val 和 Val/Val)导致病例不孕的风险显著降低(OR:0.44;95%CI:0.29-0.78,P=0.004)。这些结果支持 GSTM1 或 GSTT1 缺失基因型增加不孕风险的假说,但非缺失 GSTM1 和 GSTT1 基因型则表现为保护因素。